ArticleBMC bioinformatics2025
DualGCN-GE: integration of spatiotemporal representations from whole-blood expression data with dual-view graph convolution network to identify Parkinson's disease subtypes.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- M[Formula: see text]DGAT: Multi-view multi-scale dynamic graph attention network(GAT) based prediction of Parkinson's disease(PD) progression using whole-blood RNA sequencing data.Scientific reports · 2026Article
- Non-motor symptoms as critical predictors of quality of life in Parkinson's disease: a machine learning approach.Health and quality of life outcomes · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAs a typical type of neurodegenerative disorders, Parkinson's disease(PD) is characterized by significant clinical and progression heterogeneity. Based on gene expression data, reliable detection of PACE subtypes in Parkinson's disease(PD-PACE) has played a crucial role in addressing the heterogeneity of this disease. Established machine learning approaches generally adopt single-view learning schemes and employ temporal features underlying RNA sequencing data. Topological features, which are associated with gene graphs and cell graphs, were disregarded in previous works. Actually, Parkinson-specific gene graphs(PGG) could act as topological features to capture structural changes of molecular networks.
resultsUnder the framework of dual-view graph learning, this study proposes a DualGCN-GE method to identify multiple PD-PACE subtypes from whole-blood expression data, with regards of progression velocity. This DualGCN-GE method has proposed dual-view graph convolution network(GCN) to integrate temporal and topological features underlying whole-blood expression data, thus detecting PD-PACE subtypes. Experimental analysis of three benchmark datasets has validated the effectiveness and advantage of the DualGCN-GE method in the disease subtype detection task.
conclusionFor gene expression data of human blood samples, topological features have encoded unique information that are absent in temporal features. Using a collaborative fusion strategy, spatio-temporal representations extracted from whole blood expression data have improved accuracy and reliability in detecting PD-PACE subtypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.